17 dec: Tjen 42.000 kr. på en times arbejde
17 dec: Blue Capital A/S - Nyt dansk K/S udbyderselskab med erfaren ejerk..
17-12-2010 13:18:52

Banks weigh on FTSE as Moody's cuts Ireland's rating

The London Stock Exchange building is seen in central London
Relateret indhold

By David Brett

LONDON (Reuters) - Banks pulled top shares lower around midday on Friday, as concerns over Ireland's debt situation weighed on the sector after Moody's slashed the country's credit rating.

By 11:39 a.m., the FTSE 100 was down 10.63 points, or 0.2 percent, at 5,870.49.

Banks were led lower by Royal Bank of Scotland (Royal Bank of Scotland Group P), down 2.2 percent, on persistent concerns over euro zone debt, as Moody's Investors Service cut Ireland's credit rating by five notches to Baa1 from Aa2 and said further downgrades could follow.

"Europe's sovereign debt problems are hampering the FTSE's progress," said Jimmy Yates, head of equities and CMC Markets.

"Until a firm resolution is agreed by EU leaders, London's blue chips will struggle to break above recent highs (5,907.10) before the year-end."

Elsewhere among the fallers, AstraZeneca (Astrazeneca PLC ORD SHS $0.25) slipped 5.3 percent after its new heart medicine Brilinta failed to win approval from U.S. regulators.

UK REITS RISE

FTSE 100 real estate investment trust companies British Land (British Land Company PLC ORD 2), Hammerson (Hammerson PLC ORD 25P) and Land Securities Group (Land Securities Group PLC ORD) rose 0.8-2.5 percent as Credit Suisse upgraded its stance on the sector to "overweight" in a strategy note.

Mid-cap UK real estate firms were also boosted as Barclays Capital started its coverage of three of the firms in the sector, Derwent London (Derwent London PLC ORD 5P), Capital & Counties and Great Portland Estates (Great Portland Estates PLC ORD), with an "overweight" stance, pushing the shares up 1.4-2.1 percent.

Software group Autonomy Corp climbed 2.7 percent, aided by an upgrade in its target price by Panmure Gordon in a note that highlighted strong results from U.S. tech firms.

Airplane parts maker GKN (GKN PLC ORD 10P) rose 0.9 percent, adding to gains of 3 percent made on Thursday, helped by an upgrade in rating from Societe Generale and ahead of a pre-Christmas trading statement.

On the second line, retailers suffered, with Dixons (Dixons Retail PLC ORD 2.5P) down 5.3 percent as UBS downgraded its rating on the electrical retailer to "neutral" from "buy" and kept its "underweight" stance on the non-food retail sector.

Fashion retailer SuperGroup (Supergroup PLC ORD 5P) was the top FTSE 250 loser, down 6.2 percent, extending losses since its first-half results on Wednesday.

There was no important British economic data due on Friday, but investors will keep an eye on U.S. November lead indicators, which are scheduled for release at 1500 GMT.

(Editing by Will Waterman)

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo Nordisk/Goldman: Diabetestablet vil få den høje vækst tilbage

19-01-2018 15:11:36
Novo Nordisk står med et meget stærkt kort på hånden, hvis selskabet får en tabletudgave af det store væksthåb Ozempic (Semaglutid) godkendt og sendt på markedet.Det mener den amerikanske investeringsbank Goldman Sachs, der vurderer, at investorerne på aktiemarkedet ikke har taget tilstrækkeligt højde for de store muligheder for diabetesmidlet.Derfor har banken hævet sit kursmål for Novo Nordisk-a..

WDH/SEB: Amerikansk høreapparatmarked vokser mere end ventet

19-01-2018 14:35:39
Der var mere fart på den private del af det amerikanske høreapparatmarked i slutningen af 2017, end den svenske bank SEB havde ventet.Det skriver Bloomberg News på baggrund af en analyse fra SEB.Den private del af det amerikanske høreapparatmarked voksede 7,3 pct. i fjerde kvartal mod 2,8 pct. i tredje kvartal ifølge tal fra American Hearing Aid Association. Det var højere, end SEB har ventet, og ..

Aktier/åbning: Børshuse skubber Chr. Hansen og Novo til tops

19-01-2018 09:23:02
Chr. Hansen og Novo Nordisk er strøget til tops på det danske aktiemarked og medvirker til at hive det danske C25-indeks i et solidt plus fredag morgen.Stemningen var ellers svagt negativ i futuremarkedet indtil kort før åbningen.C25-indekset stiger 0,5 pct. til 1160,09 og ligger til et samlet plus på 0,8 pct. i denne uge.Især Chr. Hansen er sprunget i vejret fra åbningen. Aktien stiger 3,9 pct. t..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Genmab får hastebehandlet Darzalex-ansøgning i USA
2
Aktier/tendens: Genmab kan tage fokus i forventet nervøs åbning
3
Sanofi køber Bioverativ for 11,6 mia. dollar
4
Genmab: Partner indstiller markedsføring af Arzerra i CLL uden for USA
5
USA står op til lammet statsapparat efter udskudt afstemning

Relaterede aktiekurser

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. januar 2018 09:00:34
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180112.1 - EUROWEB1 - 2018-01-22 09:00:34 - 2018-01-22 09:00:34 - 1 - Website: OKAY